Invention Grant
- Patent Title: Immunogenic composition
-
Application No.: US16179476Application Date: 2018-11-02
-
Publication No.: US11241495B2Publication Date: 2022-02-08
- Inventor: Ralph Leon Biemans , Dominique Boutriau , Carine Capiau , Philippe Denoel , Pierre Duvivier , Jan Poolman
- Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Applicant Address: BE Rixensart
- Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
- Current Assignee Address: BE Rixensart
- Agency: Seed IP Law Group LLP
- Priority: GB0513069 20050627,GB0513071 20050627,GB0515556 20050728,GB0524204 20051128,GB0526040 20051221,GB0526041 20051221
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/385 ; A61K39/095 ; C07H3/00 ; A61K39/102 ; A61K39/116 ; A61K39/05 ; A61K39/08 ; A61K39/09 ; A61K39/02 ; A61K39/29 ; A61K39/145 ; C12N7/00 ; A61K39/12
Abstract:
The present application discloses an immunogenic composition comprising N. meningitidis capsular polysaccharides from at least one of serogroups A, C, W135 and Y conjugated to a carrier protein to produce a N. meningitidis capsular polysaccharide conjugate, wherein the average size of each N. meningitidis polysaccharide is above 50 kDa.
Public/Granted literature
- US20190298822A1 IMMUNOGENIC COMPOSITION Public/Granted day:2019-10-03
Information query
